These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16472148)
1. Cilostazol: therapeutic potential against focal cerebral ischemic damage. Hong KW; Lee JH; Kima KY; Park SY; Lee WS Curr Pharm Des; 2006; 12(5):565-73. PubMed ID: 16472148 [TBL] [Abstract][Full Text] [Related]
2. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats. Lee JH; Kim KY; Lee YK; Park SY; Kim CD; Lee WS; Rhim BY; Hong KW J Pharmacol Exp Ther; 2004 Mar; 308(3):896-903. PubMed ID: 14634032 [TBL] [Abstract][Full Text] [Related]
3. Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation. Hong KW; Kim KY; Shin HK; Lee JH; Choi JM; Kwak YG; Kim CD; Lee WS; Rhim BY J Pharmacol Exp Ther; 2003 Sep; 306(3):1182-90. PubMed ID: 12807996 [TBL] [Abstract][Full Text] [Related]
4. Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells. Kim KY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Shin YW; Hong KW J Pharmacol Exp Ther; 2004 Jan; 308(1):97-104. PubMed ID: 14569058 [TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/Akt/ cyclic AMP response element binding protein via maxi-K channel opening in neuronal cells. Kim KY; Lee JH; Park JH; Yoo MA; Kwak YG; Kim SO; Yoo SE; Hong KW Eur J Pharmacol; 2004 Aug; 497(3):267-77. PubMed ID: 15336944 [TBL] [Abstract][Full Text] [Related]
6. 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Choi YC; Lee JH; Hong KW; Lee KS Fundam Clin Pharmacol; 2004 Oct; 18(5):547-57. PubMed ID: 15482376 [TBL] [Abstract][Full Text] [Related]
7. Protective effects of cilostazol against transient focal cerebral ischemia and chronic cerebral hypoperfusion injury. Lee JH; Park SY; Shin HK; Kim CD; Lee WS; Hong KW CNS Neurosci Ther; 2008; 14(2):143-52. PubMed ID: 18482026 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. Choi JM; Shin HK; Kim KY; Lee JH; Hong KW J Pharmacol Exp Ther; 2002 Mar; 300(3):787-93. PubMed ID: 11861782 [TBL] [Abstract][Full Text] [Related]
9. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation]. Ishiguro M; Hara H Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790 [TBL] [Abstract][Full Text] [Related]
10. Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation. Park SY; Lee JH; Kim CD; Lee WS; Park WS; Han J; Kwak YG; Kim KY; Hong KW J Pharmacol Exp Ther; 2006 Jun; 317(3):1238-45. PubMed ID: 16547169 [TBL] [Abstract][Full Text] [Related]
11. Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia. Tanaka Y; Tanaka R; Liu M; Hattori N; Urabe T Neuroscience; 2010 Dec; 171(4):1367-76. PubMed ID: 20933581 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia. Shichinohe H; Tan C; Abumiya T; Nakayama N; Kazumata K; Hokari M; Houkin K; Kuroda S Brain Res; 2015 Mar; 1602():53-61. PubMed ID: 25617822 [TBL] [Abstract][Full Text] [Related]
13. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Watanabe T; Zhang N; Liu M; Tanaka R; Mizuno Y; Urabe T Stroke; 2006 Jun; 37(6):1539-45. PubMed ID: 16645134 [TBL] [Abstract][Full Text] [Related]
14. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318 [TBL] [Abstract][Full Text] [Related]
15. Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke. Kim YR; Kim HN; Hong KW; Shin HK; Choi BT Psychopharmacology (Berl); 2016 Mar; 233(6):1055-66. PubMed ID: 26686236 [TBL] [Abstract][Full Text] [Related]
16. Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats. Ito H; Hashimoto A; Matsumoto Y; Yao H; Miyakoda G J Cereb Blood Flow Metab; 2010 Feb; 30(2):343-51. PubMed ID: 19809463 [TBL] [Abstract][Full Text] [Related]
17. 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (cilostazol), a phosphodiesterase type 3 inhibitor, reduces infarct size via activation of mitochondrial Ca2+-activated K+ channels in rabbit hearts. Fukasawa M; Nishida H; Sato T; Miyazaki M; Nakaya H J Pharmacol Exp Ther; 2008 Jul; 326(1):100-4. PubMed ID: 18381926 [TBL] [Abstract][Full Text] [Related]
18. Cilostazol, a phosphodiesterase 3 inhibitor, protects mice against acute and late ischemic brain injuries. Ye YL; Shi WZ; Zhang WP; Wang ML; Zhou Y; Fang SH; Liu LY; Zhang Q; Yu YP; Wei EQ Eur J Pharmacol; 2007 Feb; 557(1):23-31. PubMed ID: 17161838 [TBL] [Abstract][Full Text] [Related]
19. The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat. Toda Y; Katsura K; Saito M; Inaba T; Sakurazawa M; Katayama Y Neurol Res; 2014 Nov; 36(11):1011-9. PubMed ID: 24836463 [TBL] [Abstract][Full Text] [Related]
20. An oral administration of cilostazol before focal ischemia reduces the infarct volume with delayed cerebral blood flow increase in rats. Yuzawa I; Yamada M; Fujii K J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):281-6. PubMed ID: 18755408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]